SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-021119
Filing Date
2022-08-22
Accepted
2022-08-22 15:00:49
Documents
82
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cenb20220630_10q.htm   iXBRL 10-Q 1220252
2 EXHIBIT 31.1 ex_414044.htm EX-31.1 9006
3 EXHIBIT 32.1 ex_414045.htm EX-32.1 4554
  Complete submission text file 0001437749-22-021119.txt   7281676

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cenb-20220630.xsd EX-101.SCH 85962
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cenb-20220630_cal.xml EX-101.CAL 50111
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cenb-20220630_def.xml EX-101.DEF 554194
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE cenb-20220630_lab.xml EX-101.LAB 450977
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cenb-20220630_pre.xml EX-101.PRE 584822
76 EXTRACTED XBRL INSTANCE DOCUMENT cenb20220630_10q_htm.xml XML 1080052
Mailing Address 300-3295 QUALITY WAY WINDSOR A6 N8T 3R9
Business Address 300-3295 QUALITY WAY WINDSOR A6 N8T 3R9 226-344-0660
CEN BIOTECH INC (Filer) CIK: 0001653821 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55557 | Film No.: 221183540
SIC: 2834 Pharmaceutical Preparations